AstraZeneca Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 729,365 | 0.047% |
Public Companies | 777,613 | 0.0502% |
Private Companies | 1,913,838 | 0.123% |
State or Government | 2,368,774 | 0.153% |
General Public | 218,551,443 | 14.1% |
Institutions | 1,325,893,992 | 85.5% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
134,735,914 | US$20.9b | -1.85% | 0.37% | |||
132,519,021 | US$20.5b | -1.05% | 1.03% | |||
78,191,090 | US$12.1b | -0.36% | 1.83% | |||
70,081,396 | US$10.9b | 1.58% | 0.18% | |||
51,587,810 | US$8.0b | 0% | 11.92% | |||
49,101,471 | US$7.6b | 0.05% | 0.69% | |||
35,535,698 | US$5.5b | 0.24% | 0.47% | |||
32,493,006 | US$5.0b | -0.09% | 0.33% | |||
26,570,403 | US$4.1b | 1.25% | 0.82% | |||
26,103,533 | US$4.0b | 0.03% | 0.16% | |||
24,870,466 | US$3.9b | -0.64% | 3.53% | |||
21,493,537 | US$3.3b | -2.06% | 2.42% | |||
19,891,699 | US$3.1b | 4.77% | 0.41% | |||
16,907,448 | US$2.6b | 1.41% | 1.32% | |||
16,876,481 | US$2.6b | 19.3% | 0.55% | |||
13,616,076 | US$2.1b | -4.96% | 1.34% | |||
12,616,644 | US$2.0b | -1.12% | 0.24% | |||
12,284,525 | US$1.9b | 6.96% | 2.66% | |||
11,386,858 | US$1.8b | -0.16% | 2.24% | |||
10,842,928 | US$1.7b | -2.71% | 1.25% | |||
10,634,191 | US$1.6b | -0.12% | 0.26% | |||
10,338,888 | US$1.6b | -3.43% | 0.38% | |||
10,050,649 | US$1.6b | -1.73% | 0.66% | |||
9,830,243 | US$1.5b | 0.73% | 0.4% | |||
9,625,108 | US$1.5b | -2.45% | 0.94% |